Full-Time

Head of Regulatory Strategy

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior, Expert

Toronto, ON, Canada

Expected to be in office 70% of the time with flexibility to work from home up to 30%.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Bachelor’s Degree in Life Science or related discipline; advanced degree preferred (PharmD, MSc, PhD)
  • 10+ years of experience in the pharmaceutical industry
  • 8+ years of experience in Regulatory strategy
  • Strong knowledge of current local (Canada), US, and international regulations related to clinical, nonclinical, and regulatory requirements for innovative medicines
  • Solid experience with eCTD and regulatory filings
  • Knowledge of and specific experience with regulatory procedures and legislation for drug development, product registration, line extension, and license maintenance in Canada and International countries
  • Experience and knowledge in the preparation of major regulatory submissions and supportive amendments or supplements
  • Ability to work independently to manage multiple projects in a fast-paced environment
  • Ability to lead and collaborate effectively in a dynamic cross-functional matrix environment to drive meeting each program’s critical regulatory milestones
  • Outstanding communication skills (verbal and written) and willingness to share knowledge and lessons learned
  • Fluency in English (French is an asset)
Responsibilities
  • Defining and leading regulatory strategy for assigned projects and jurisdictions in collaboration with local, regional, and global leadership
  • Managing and developing regulatory submissions and documents, including NDS, DSURs, PSURs, orphan drug designations, and more
  • Ensuring compliance with Canadian regulatory requirements and maintaining necessary business licenses
  • Building and leading the regulatory team to meet key milestones and business objectives
  • Leading strategic interactions with Health Canada and other regulatory agencies, providing a single point of contact
  • Supporting commercial execution from a regulatory perspective, including artwork and promotional material reviews and training for local business teams
  • Collaborating effectively with cross-functional teams to assess regulatory risks and implement mitigation strategies
  • Delivering effective presentations and communications to internal and external stakeholders
  • Supporting the broader global regulatory strategy and ensuring alignment with Moderna's business objectives in Canada
Desired Qualifications
  • Advanced degree preferred (PharmD, MSc, PhD)
  • A desire to be part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to harness the power of mRNA to improve patient outcomes and create effective treatments for a range of diseases.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

2%

2 year growth

4%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna received $176 million to develop a bird flu vaccine in July 2024.
  • The U.S. government supports Moderna's mRNA pandemic influenza vaccine development.
  • Moderna's mRNA technology is being explored for personalized cancer vaccines.

What critics are saying

  • Decreasing COVID-19 vaccine demand impacts Moderna's stock and revenue forecast.
  • Moderna's potential Nasdaq 100 removal could affect investor confidence.
  • Bypassing safety steps in Australia may lead to regulatory scrutiny and backlash.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for a new class of medicines.
  • The company focuses on mRNA-based vaccines for pandemic influenza and other viruses.
  • Moderna collaborates with AI firms to accelerate drug discovery processes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend